Pinkeye Shield XT4 (Canada)This page contains information on Pinkeye Shield XT4 for veterinary use.
The information provided typically includes the following:
- Pinkeye Shield XT4 Indications
- Warnings and cautions for Pinkeye Shield XT4
- Direction and dosage information for Pinkeye Shield XT4
Pinkeye Shield XT4This treatment applies to the following species:
Moraxella Bovis Bacterin
For Use In Animals Only
Pinkeye Shield XT4 Indications
For use in healthy cattle as an aid in the prevention of pinkeye caused by Moraxella bovis.
ADJUVANT: Xtend™ SP.
Directions For Use
Shake well before using. Administer 2 mL intramuscularly in the neck. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended.
PrecautionsStore out of direct sunlight at 2°-8°C (35°-46°F). DO NOT FREEZE. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of the injection. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains thimerosal as a preservative.
Manufactured by Elanco US Inc., Larchwood, IA, USA.
USDA Vet. Biologics Est. Lic. No. 196.
For Elanco Canada Limited, Guelph, Ontario, Canada N1G 4T2 1-800-265-5475.
Elanco, Pinkeye Shield, Xtend and the diagonal bar are trademarks owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates.
(successor to Novartis Animal Health Canada Inc.)
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
|Every effort has been made to ensure the accuracy of the Pinkeye Shield XT4 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-09-03